UA96455C2 - Transmucosal delivery devices with enhanced uptake - Google Patents

Transmucosal delivery devices with enhanced uptake

Info

Publication number
UA96455C2
UA96455C2 UAA200901454A UAA200901454A UA96455C2 UA 96455 C2 UA96455 C2 UA 96455C2 UA A200901454 A UAA200901454 A UA A200901454A UA A200901454 A UAA200901454 A UA A200901454A UA 96455 C2 UA96455 C2 UA 96455C2
Authority
UA
Ukraine
Prior art keywords
medicament
subject
delivery devices
transmucosal
transmucosal delivery
Prior art date
Application number
UAA200901454A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Нирадж ВАСИШТ
Эндрю ФИНН
Original Assignee
Биоделивери Сайенсиз Интернешнл, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биоделивери Сайенсиз Интернешнл, Инк. filed Critical Биоделивери Сайенсиз Интернешнл, Инк.
Publication of UA96455C2 publication Critical patent/UA96455C2/en

Links

Abstract

The present invention provides methods for enhancing transmucosal uptake of a medicament, e.g., fentanyl or buprenorphine, to a subject and related devices. The method includes administering to a subject a transmucosal drug delivery device comprising the medicament. Also provided are devices suitable for transmucosal administration of a medicament to a subject and methods of their administration and use. The devices include a medicament disposed in a mucoadhesive polymeric diffusion environment and a barrier environment.
UAA200901454A 2006-07-21 2007-07-23 Transmucosal delivery devices with enhanced uptake UA96455C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83272606P 2006-07-21 2006-07-21

Publications (1)

Publication Number Publication Date
UA96455C2 true UA96455C2 (en) 2011-11-10

Family

ID=50839002

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200901454A UA96455C2 (en) 2006-07-21 2007-07-23 Transmucosal delivery devices with enhanced uptake

Country Status (1)

Country Link
UA (1) UA96455C2 (en)

Similar Documents

Publication Publication Date Title
MX2009000745A (en) Transmucosal delivery devices with enhanced uptake.
CY1118392T1 (en) PROVISIONAL INTERMEDIATE ADMINISTRATION PROVIDING INTERFERENCE TO ABUSE
ATE474564T1 (en) SMALL VOLUME, ORAL, TRANSMUCOSAL DOSAGE FORMS OF SUFENTANIL FOR PAIN TREATMENT
EP2708256A3 (en) Device and method for delivery of a medicament
MX2013009773A (en) Chewable vehicle for mouth absorption.
BRPI0418228A (en) dosage form, and methods of treating pain and incident cancer pain episodes, and preparing a tablet for oral, gingival or sublingual administration of fentanyl
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
WO2007103293A3 (en) Ethanol-resistant sustained release formulations
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
EP1824410A4 (en) Systems and methods for intra-oral drug delivery
MY163809A (en) Transdermal drug delivery system containing donepezil
PT2056825E (en) Use of opioid formulations in needle-less drug delivery devices
MX2015007678A (en) Transmucosal delivery of glatiramer acetate.
BR112013011942A2 (en) formulation, drug dosage form for oral transmucosal administration, transmucosal drug delivery system, method of treatment and prophylaxis of a disease or disorder, method of treatment, formulation, method for treatment or prevention of head and neck squamous cell carcinoma (hnscc), method for chemoprevention of an oral cancer or precancerous condition, method for increasing the concentration of a retinide composition, method of treatment and prophylaxis of a disease or condition, ratification method of a subject presenting a symptomatic medical condition , method of treating an oral cancer or precancerous condition in a patient, method for making an oral drug delivery system, method for increasing the release and permeation of a retinide composition.
UA105944C2 (en) Drug formulation with theobromine and decongestant for treatment of cough
TW200611697A (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
MA31227B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING PHLOROGLUCINOL AND PARACETAMOL.
UA96455C2 (en) Transmucosal delivery devices with enhanced uptake
MX2012005849A (en) Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells.
WO2010022277A3 (en) Combination of 10-propargyl-10-deazaaminopterin and bortezomib for the treatment of cancers
WO2013096811A3 (en) Transmucosal drug delivery devices for use in chronic pain relief
CY1117450T1 (en) CONVENIENCE ADVISORY PROVISIONS WITH IMPROVED ATTENTION
AU2018260865A1 (en) Multidirectional mucosal delivery devices and methods of use
WO2005011589A3 (en) Drug delivery methods and devices
NZ724912A (en) Transmucosal drug delivery devices for use in chronic pain relief